-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: BIO
2010 in review
The stats helper monkeys at WordPress.com mulled over how this blog did in 2010, and here’s a high level summary of its overall blog health: The Blog-Health-o-Meter™ reads This blog is on fire!. Crunchy numbers The average container ship can carry about 4,500 containers. This blog was viewed about 20,000 times in 2010. If each view were a shipping container, your blog would have filled about 4 fully loaded ships. In 2010, there were 27 Read More >
AUTM’s 2010 Better World Report Highlights
AUTM released their Better World Report for 2010 highlighting academic innovations commercially developed through technology transfer that are improving the quality of life. Here is a quote from their press release. A device that allows the blind to ―see‖ via electrical pulses applied to the tongue…a collagen scaffold to treat damaged joints…a new vaccine to prevent shingles…an artificial lung that provides patients with both mobility and comfort during treatment…a program that vastly improves literacy among Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: Association of Technology Transfer Managers, AUTM, Bayh-Dole, BIO, biotechnology, economic development, federally funded research, Global Health, government funded research, healthcare, Licensing technology, modern medicine, new drug development, NIH, patents, Research and Development, Senator Birch Bayh, Senator Dole
Tags: Association of Technology Transfer Managers, AUTM, Bayh-Dole, BIO, biotechnology, economic development, federally funded research, Global Health, government funded research, healthcare, Licensing technology, modern medicine, new drug development, NIH, patents, Research and Development, Senator Birch Bayh, Senator Dole
Is the Myriad Case Decision and/or the DOJ Brief TRIPS Compliant?
Judge Sweet seemed to dismiss Myriad’s constitutional taking and TRIPS claims by indicating: “Finally, Myriad’s suggestion that invalidating the patents-in-suit would constitute an unconstitutional taking in violation of the Fifth Amendment of the Constitution or a violation of the United States’ obligations under the Agreement on Trade-Related Aspects of Intellectual Property Rights (“TRIPS”) is unpersuasive. Myriad’s novel taking argument runs counter to a long history of invalidation of patent claims by the courts and is unsupported by legal Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: BIO, Department of Justice, DNA, DNA patents, DOJ, gene, Gene Patents, gene patents, Global Health, International, International law, isolated and purified DNA, isolated DNA, Judge Sweet, Myriad, Patent Reform, patents, TRIPS, United States Patent and Trademark Office
Tags: BIO, Department of Justice, DNA, DNA patents, DOJ, gene, Gene Patents, gene patents, Global Health, International, International law, isolated and purified DNA, isolated DNA, Judge Sweet, Myriad, Patent Reform, patents, TRIPS, United States Patent and Trademark Office
BIO’s Comments on proposed PTO Humanitarian Technologies and Licensing Through the Intellectual Property System
Here are the highlights from BIO’s recent submission on the proposed PTO “Request for Comments on Incentivizing Humanitarian Technologies and Licensing Through the Intellectual Property System.” Background: 1. “BIO’s members also understand that problems with access to medicines and other biotechnology products in the developing world have very little to do with the patent system, and are generally caused by other factors outside the control of individual stakeholders, such as lack of adequate local manufacturing, Read More >
Patently BIOtech
1 Comment
Email This Post
Tags: access to medicines, BIO, BIOTECH, biotechnology, Biotechnology Industry Organization, developing countries, economic development, Global Health, Green Technology, humanitarian, humanitarian technologies, International, Patent and Trademark Office, Patent Reform, patents, poverty, PTO, re-examination vouchers, U.S. Patent and Trademark Office, United States Patent and Trademark Office, USPTO
Tags: access to medicines, BIO, BIOTECH, biotechnology, Biotechnology Industry Organization, developing countries, economic development, Global Health, Green Technology, humanitarian, humanitarian technologies, International, Patent and Trademark Office, Patent Reform, patents, poverty, PTO, re-examination vouchers, U.S. Patent and Trademark Office, United States Patent and Trademark Office, USPTO
AUTM Bayh-Dole 30th Anniversary Event
Association of University Technology Managers Press Release Deerfield, IL — December 12, 2010 will mark the 30th anniversary of the Bayh-Dole Act. This legislation changed fundamentally the way America develops technologies from federally funded university research and effectively secured the country’s leadership position in innovation. As a result of Bayh-Dole, more than 6,000 new U.S. companies formed from university technologies, approximately 5,000 new products are on the market, 153 new drugs, vaccines or in vitro Read More >
